Market Checkup: High Cholesterol

In this edition of The Motley Fool's Market Checkup, health-care analysts David Williamson and Max Macaluso discuss the treatment of high cholesterol. From the impact of generic versions of Pfizer's Lipitor to the most exciting experimental drugs in late-stage clinical trials, cholesterol continues to be an area of focus for pharmaceutical companies and investors.

One of the best parts of owning big pharma stocks is their attractive dividends, but smart investors know the importance of diversifying -- seeking high-yielding stocks from multiple industries. The Motley Fool's special free report "Secure Your Future With 9 Rock-Solid Dividend Stocks" outlines the Fool's favorite dependable dividend-paying stocks across all sectors. Grab your free copy by clicking here.


Read/Post Comments (0) | Recommend This Article (4)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2544129, ~/Articles/ArticleHandler.aspx, 11/26/2014 11:16:23 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated Moments ago Sponsored by:
DOW 17,809.70 -5.24 -0.03%
S&P 500 2,068.97 1.94 0.09%
NASD 4,772.21 13.95 0.29%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

11/26/2014 11:01 AM
ACT $268.24 Down -2.07 -0.77%
ACTAVIS CAPS Rating: ****
AEGR $21.53 Up +0.07 +0.33%
Aegerion Pharmaceu… CAPS Rating: *
ALNY $98.52 Up +1.31 +1.35%
Alnylam Pharmaceut… CAPS Rating: ***
AMGN $163.25 Up +1.01 +0.62%
Amgen, Inc. CAPS Rating: ****
AMRN $1.28 Up +0.06 +4.91%
Amarin Corp plc (A… CAPS Rating: ****
AZN $73.76 Up +0.10 +0.14%
AstraZeneca plc (A… CAPS Rating: ****
GIS $51.74 Up +0.09 +0.17%
General Mills, Inc… CAPS Rating: ****

Advertisement